Tamoxifen has a proliferative effect in endometrial carcinoma mediated via the GPER/EGFR/ERK/cyclin D1 pathway: A retrospective study and an in vitro study-Reference-Cited by-同舟云学术

Tamoxifen has a proliferative effect in endometrial carcinoma mediated via the GPER/EGFR/ERK/cyclin D1 pathway: A retrospective study and an in vitro study

Published:2016-12 Issue: Volume:437 Page:51-61
ISSN:0303-7207
Container-title:Molecular and Cellular Endocrinology
language:en
Short-container-title:Molecular and Cellular Endocrinology

Author:

Zhang Lizhi,Li Yanmin,Lan Lan,Liu Rong,Wu Yanhong,Qu Quanxin,Wen Ke

Funder

Chinese Natural Science Foundation

Publisher

Elsevier BV

Subject

Endocrinology,Molecular Biology,Biochemistry

Reference41 articles.

1. Tamoxifen use in breast cancer patients who subsequently develop corpus cancer is not associated with a higher incidence of adverse histologic features;Barakat;Gynecol. Oncol.,1994

2. Risk and prognosis of endometrial cancer after tamoxifen for breast cancer. Comprehensive Cancer Centres' ALERT Group;Bergman;Lancet,2000

3. Relationship between tamoxifen use and high risk endometrial cancer histologic types;Bland;Gynecol. Oncol.,2009

4. Etiologic heterogeneity in endometrial cancer: evidence from a Gynecologic Oncology Group trial;Brinton;Gynecol. Oncol.,2013

5. Downstream targets of growth factor and oestrogen signalling and endocrine resistance: the potential roles of c-Myc, cyclin D1and cyclin E;Butt;Endocr. Relat. Cancer,2005

Cited by 30 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The G Protein-Coupled Estrogen Receptor GPER in the Development and Progression of Cancer;Receptors;2024-05-27

2. Enhancing Tamoxifen Therapy with α-Mangostin: Synergistic Antiproliferative Effects on Breast Cancer Cells and Potential Reduced Endometrial Impact;Pharmaceuticals;2023-11-08

3. MicroRNA and gynecological cancers: Focus on miR-195;Pathology - Research and Practice;2023-09

4. Fumarate hydratase functions as a tumor suppressor in endometrial cancer by inactivating EGFR signaling;Oncology Reports;2023-08-23

5. Casein kinase 1 controls the shuttling of epidermal growth factor receptor and estrogen receptor in endometrial carcinoma induced by breast cancer hormonal therapy: Relevance of GPER1/Src;Cellular Signalling;2023-08